While crafting a personal or company brand, it is important to connect your business idea to your purpose and passion. Photo via Getty Images

Every business, whether a single member consultancy, a small startup, or a large corporation, owns a brand. One can think of a brand in a number of different ways — a recognizable logo, a catchy name, an inspirational tagline, or even a feeling one gets when using a certain product or service.

At its core, branding begins with values. Whether you are building a personal brand or a company brand, it is essential to ascertain your purpose and passion and then connect it with your business idea.

In this article, I am going to walk you through tips on building a personal and company brand.

Personal Brand

Gary Vaynerchuk, successful entrepreneur and internet personality who built his personal brand on digital marketing, said “You have to understand your own personal DNA.” Here are some key points to consider when developing your personal brand:

Play to your individual strengths

You do not need to do everything! If you love writing, do a blog. If you prefer talking, focus on videos. If you can commit to posting online every day, take on social media channels like Instagram & Twitter.

Leverage your network

Networks are a powerful tool and most importantly, do not require you to spend loads of marketing dollars. It is a huge misconnection that branding is a cost center for all businesses. There are many ways to promote your brand without significant cost. Here are some simple ideas to get you started:

  1. Create an online presence (website, social media channels, blogs, etc.)
  2. Develop a content calendar and post/update regularly, at least once a week
  3. Read a lot and reach out to journalists who write in your industry
  4. Seek out speaking opportunities at conferences or apply for awards that recognize leaders like you – don’t shy away from nominating yourself!

Be well-rounded

Running your own brand can sometimes make work/life balance feel enmeshed, making you feel like you are losing your own identity. Don’t forget to diversify yourself. Volunteer at a charity or nonprofit of choice, share photos of your friends and family spending time together, get involved with a professional organization, and promote yourself.

Company brand

When building a company brand, it is essential to identify and understand your target audience by creating clear customer profiles. Commercial brands only succeed when they can connect their business and values to a customer. When I work on branding exercises with companies, I always start with a value proposition canvas. Once you clearly define the values and target market, these are some beneficial next steps:

Craft a cohesive vision and mission statement

A vision statement is aspirational or pie in the sky, alluding to what your organization will achieve in the future. A mission statement is definitional, describing your business objectives and how you will get there. Together, these succinct messages should help your customer fully understand what you are selling or offering.

Create a unique and consistent visual identity

A visual identity is what helps a brand stand on its own without needing someone to explain it. This can include a color scheme, fonts, logo – anything that will contribute to your company’s brand guidelines. Especially for companies in highly competitive markets like food & beverage, a recognizable visual identity can make or break a brand’s ultimate success.

Take your time

I recently listened to the How I Built This podcast episode featuring Bombas. I was amazed to hear that they tested over 100 fabric combinations for their first sock before finalizing it. Today, they are probably one of the most popular and recognizable brands in the sock business. Some companies need to launch right away but as long as you can learn, grow, and pivot when needed, time can be on your side. A quality product is better than a rushed product.

___

Arielle Rogg is the principal and founder of Rogg Enterprises, a Houston-based company providing digital marketing for health care innovators.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

  • 2024 Google search volume for terms related to investing
  • Number of investors
  • Number of businesses receiving investments in 2024
  • Total amount of capital invested in businesses in 2024
  • Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.